n Vitro maturation (IVM) of human oocytes is an emerging infertility treatment with great promise. For successful assisted reproductive technology.
There must be both nuclear and cytoplasmic maturation of the oocytes and give rise to human embryos that have the same developmental potential as embryos resulting from the golden standard of human IVF.
The aspiration of immature oocytes from small to medium size antral follicles followed by their maturation In Vitro present an attractive alternative to the hormonal stimulation of patients in In Vitro Fertilization (IVF) treatment.
Administration of exogenous hormones is a costly treatment and if there is a resistance to follicular growth or risk of OHSS (e.g.: in Patients with low ovarian reserve, Severe PCOD patients) IVM is a viable option